RecruitingNCT06189755

MicroRNAs as Biomarkers for Obstructive Sleep Apnea

Sponsor

University of Pennsylvania

Enrollment

500 participants

Start Date

Apr 1, 2024

Study Type

OBSERVATIONAL

Conditions

Obstructive Sleep Apnea

Summary

Although obstructive sleep apnea (OSA) is a common disorder, there are no blood biomarkers for identification and management of these patients. This project will study microRNAs in order to develop and validate blood biomarkers that are specific to OSA, useful for identification of cases with OSA, reflective of efficacy of therapy, and able to predict blood pressure response to treatment of OSA.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Positive Airway Pressure for people with obstructive sleep apnea. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPositive Airway Pressure

Case participants will use Positive Airway Pressure (PAP) treatment as part of routine clinical care.

Locations(3)

The Ohio State University - Martha Morehouse Medical Pavilion, Suite 2600

Columbus, Ohio, United States

University of Pennsylvania

Philadelphia, Pennsylvania, United States

University of Iceland

Reykjavik, Iceland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06189755

Related Trials

Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation

NCT0744437227 locations

Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study

NCT048144203 locations

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

NCT0722568660 locations

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

NCT0722676554 locations

Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)

NCT041799811 location